246 related articles for article (PubMed ID: 16572411)
1. Breast cancer incidence after the introduction of mammography screening: what should be expected?
Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
3. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
4. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
5. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
6. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
[TBL] [Abstract][Full Text] [Related]
8. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
[TBL] [Abstract][Full Text] [Related]
10. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
11. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
12. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen].
Hirsch FR; Mouridsen HT; Hansen OP; Jørgensen T; Blichert-Toft M; Rank FE; Jensen MB
Ugeskr Laeger; 1996 Feb; 158(9):1218-21. PubMed ID: 8644426
[TBL] [Abstract][Full Text] [Related]
14. Mammography screening and the increase in breast cancer incidence in Hawaii.
Maskarinec G; Wilkens L; Meng L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):201-8. PubMed ID: 9138664
[TBL] [Abstract][Full Text] [Related]
15. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
Richardson A; Graham P; Brown T; Smale P; Cox B
J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
[TBL] [Abstract][Full Text] [Related]
17. Outcomes among women younger than age 40 in a state breast cancer screening program.
Vetto JT; Wheeler AJ; Toomey M; Schmidt KJ
Am J Surg; 2006 May; 191(5):635-40. PubMed ID: 16647351
[TBL] [Abstract][Full Text] [Related]
18. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
19. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
20. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
Hofvind S; Thoresen S; Tretli S
Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]